Search

everythinglearnresearchcommunity

for

Search:↓

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Lasers are effective and safe for various medical treatments, including cancer, wound healing, and skin conditions.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Some herbal therapies may help with skin conditions, but more research is needed to confirm their safety and effectiveness.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Nanoparticle systems make cancer treatment less toxic.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Finasteride helps reduce heart issues and improves heart function.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Ethosomes improve drug delivery through the skin but may have side effects like irritation.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Reducing reactive oxygen species can help treat nerve damage from platinum cancer drugs.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Radiotherapy can cause skin fibrosis, which is often overlooked and needs better treatment and evaluation.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

The conclusion is that finasteride is linked to an increased risk of suicidal thoughts and a higher risk of completed suicide when used for hair loss.

Chemotherapy and radiation therapy cause skin and hair damage by altering gene expression and signaling pathways.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.